Why Ziopharm Oncology Stock Is Soaring Today
Shares of Ziopharm Oncology (NASDAQ: ZIOP) were soaring 11.8% as of 11:45 a.m. EST on Friday. The nice gain came after the company announced the election of Robert Postma to its board of directors. The addition expanded Ziopharm's board from eight members to nine.
The election of new board members doesn't usually provide a catalyst for a biotech stock. What's different in this case?
Image source: Getty Images.
Source Fool.com
